Boston Scientific Corp. received CE mark and began the European commercial launch of its new 25 mm Lotus transcatheter aortic valve implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes.
The Children's Hospital of Philadelphia (CHOP) launched the Fetal Neuroprotection and Neuroplasticity Program.

July 17 2014 — The Journal of the American Society of Echocardiography (JASE) announced the publication of a new consensus statement on the use of focused cardiac ultrasound (FoCUS) in its July 2014 issue.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
A study by researchers at CVS Caremark, Aetna and Brigham and Women’s Hospital published in the May issue of Health Affairs, finds that eliminating copays for preventive medications prescribed for post-heart attack patients, can significantly improve medication adherence and health outcomes for non-white patients.
CorMatrix Cardiovascular and the Central Clinical Hospital of the Ministry of Interior in Warsaw (Centralny Szpital Kliniczny MSW) of Warsaw, Poland, announced the successful enrollment and treatment of five patients in the first ever study evaluating the CorMatrix ECM delivered trans-epicardially for the improvement of myocardial function in patients at risk or suffering from congestive heart failure (CHF).
A new physician poster presentation at the Atrial Fibrillation Symposium 19th Annual International Meeting in Orlando, Fla., reports long-term outcomes for the convergent procedure, a multidisciplinary epicardial-endocardial approach to treat patients with persistent atrial fibrillation (AF)
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious — and even fatal —complications. Fortunately, at the California Institute for Deep Venous Thrombosis, those suffering from the effects of thrombosis will find an effective DVT treatment from Farshad Malekmehr.
Surgical aortic valve replacement generally improves patients’ symptoms and prolongs survival. However, the perceived risk of surgical aortic valve replacement in patients over 80 may result in surgery being denied or a recommendation for alternative therapy. Investigators at the Mayo Clinic challenge the way these patients have been managed. They report that repeat sternotomy in patients over 80 who have previously had coronary bypass graft surgery can be done with low risk. T
July 15, 2014 — Micell Technologies Inc. announced the United States Patent and Trademark Office (USPTO) has issued a patent related to Micell's technology for enhancing the performance of medical devices with precise drug-delivery coatings.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 15, 2014 — Chelation treatments reduce cardiovascular events, such as heart attacks, and death in patients with diabetes but not in those who did not have diabetes, according to analyses of data from the National Institutes of Health (NIH)-funded Trial to Assess Chelation Therapy (TACT). However, researchers say more studies are needed before it is known whether this promising finding leads to a treatment option.

July 15 2014 — Researchers at the University of California, San Diego School of Medicine have documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to repair abdominal aortic aneurysms in a study published July 9 in JAMA Surgery.
July 15, 2014 — Telemed Solutions has reached an agreement with GlobalMedia Group LLC to become the exclusive global distributor for the TM-12, a PC-based wireless resting 12-lead ECG (electrocardiography) system. GlobalMed also will act as the exclusive master distributor for order fulfillment to Telemed Solutions’ existing distributors, resellers and customers.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Tony Parris has worked for banks and electronics companies and has even driven an 18-wheel truck 995 miles a day for more than nine years as part of his working career. The 57-year-old Anniston, Ala., native finally went into business for himself when he opened his own hardware store in Alexandria, Ala., in 2010.
Objective Medical Systems LLC announced that its Electronic Health Record (EHR) system has earned Meaningful Use Stage 2 Certification from the Office of the National Coordinator for Health Information Technology.
DC Devices Inc. has closed a $34 million Series D financing round. Accelmed led the round with contributions from existing investors Third Rock Ventures, General Catalyst Partners and Lumira Capital, as well as a new undisclosed strategic investor. Funds will be used to complete clinical evaluation of the world’s first transcatheter device for the treatment of diastolic heart failure (DHF), a $5 billion global market opportunity.